Misplaced Pages

Epworth Sleepiness Scale

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

The Epworth Sleepiness Scale ( ESS ) is a scale intended to measure daytime sleepiness that is measured by use of a very short questionnaire. This can be helpful in diagnosing sleep disorders . It was introduced in 1991 by Dr Murray Johns of Epworth Hospital in Melbourne, Australia .

#28971

80-397: The questionnaire asks the subject to rate their probability of falling asleep on a scale of increasing probability from 0 to 3 for eight different situations that most people engage in during their daily lives, though not necessarily every day. The scores for the eight questions are added together to obtain a single number. A number in the 0–9 range is considered to be normal while a number in

160-524: A C O 2 {\displaystyle {P_{a_{CO_{2}}}}} have a stronger narcotic effect: Confusion and irrational behaviour may occur around 72 torrs (0.095 atm), and loss of consciousness around 90 torrs (0.12 atm). High P a C O 2 {\displaystyle {P_{a_{CO_{2}}}}} triggers the fight or flight response, affects hormone levels and can cause anxiety, irritability and inappropriate or panic responses, which can be beyond

240-598: A C O 2 {\displaystyle {P_{a_{CO_{2}}}}} ) causes changes in brain activity that adversely affect both fine muscular control and reasoning. EEG changes denoting minor narcotic effects can be detected for expired gas end tidal partial pressure of carbon dioxide ( P E T C O 2 {\displaystyle {P_{ET_{CO_{2}}}}} ) increase from 40 torrs (0.053 atm) to approximately 50 torrs (0.066 atm). The diver does not necessarily notice these effects. Higher levels of P

320-412: A C O 2 {\displaystyle {P_{a_{CO_{2}}}}} . After 30–90 min, the respiratory center was depressed, and hypotension occurred gradually or suddenly from reduced cardiac output, leading to an apnea and eventually to circulatory arrest. At higher concentrations of CO 2 , unconsciousness occurred almost instantaneously and respiratory movement ceased in 1 minute. After

400-475: A CPAP machine . With proper use, CPAP improves outcomes. Evidence suggests that CPAP may improve sensitivity to insulin, blood pressure, and sleepiness. Long term compliance, however, is an issue with more than half of people not appropriately using the device. In 2017, only 15% of potential patients in developed countries used CPAP machines, while in developing countries well under 1% of potential patients used CPAP. Without treatment, sleep apnea may increase

480-485: A hypopnea in which airflow decreases by 50 percent for 10 seconds or decreases by 30 percent if there is an associated decrease in the oxygen saturation or an arousal from sleep. To grade the severity of sleep apnea, the number of events per hour is reported as the apnea-hypopnea index (AHI). An AHI of less than 5 is considered normal. An AHI of 5–15 is mild; 15–30 is moderate, and more than 30 events per hour characterizes severe sleep apnea. The diagnosis of CSA syndrome

560-420: A 2:1 ratio of men to women, and in general more people are likely to have it with older age and obesity. Other risk factors include being overweight, a family history of the condition, allergies, and enlarged tonsils . The typical screening process for sleep apnea involves asking patients about common symptoms such as snoring, witnessed pauses in breathing during sleep and excessive daytime sleepiness . There

640-501: A consequence of profound suppression of consciousness such as opioid overdose . Normal respiration in divers results in alveolar hypoventilation resulting in inadequate CO 2 elimination or hypercapnia. Lanphier's work at the US Navy Experimental Diving Unit answered the question, "Why don't divers breathe enough?": A variety of reasons exist for carbon dioxide not being expelled completely when

720-437: A continuous positive airway pressure device. The Inspire Upper Airway Stimulation system is a hypoglossal nerve stimulator that senses respiration and applies mild electrical stimulation during inspiration, which pushes the tongue slightly forward to open the airway. There is currently insufficient evidence to recommend any medication for OSA. This may result in part because people with sleep apnea have tended to be treated as

800-506: A contributory factor in sudden infant death syndrome . Hypercapnia can induce increased cardiac output, an elevation in arterial blood pressure (higher levels of carbon dioxide stimulate aortic and carotid chemoreceptors with afferents -CN IX and X- to medulla oblongata with following chrono- and ino-tropic effects), and a propensity toward cardiac arrhythmias . Hypercapnia may increase pulmonary capillary resistance. A high arterial partial pressure of carbon dioxide ( P

880-499: A feeling of shortness of breath, but the lack of this symptom is no guarantee that the other effects are not occurring. A significant percentage of rebreather deaths have been associated with CO 2 retention. The effects of high P a C O 2 {\displaystyle {P_{a_{CO_{2}}}}} can take several minutes to hours to resolve once the cause has been removed. Blood gas tests may be performed, typically by radial artery puncture , in

SECTION 10

#1732779668029

960-425: A few minutes of apnea, circulatory arrest was seen. These findings imply that the cause of death in breathing high concentrations of CO 2 is not the hypoxia but the intoxication of carbon dioxide. The treatment for acute hypercapnic respiratory failure depends on the underlying cause, but may include medications and mechanical respiratory support. In those without contraindications, non-invasive ventilation (NIV)

1040-519: A higher likelihood of developing Alzheimer's in older age, and if one has Alzheimer's then one is also more likely to have sleep apnea. This is demonstrated by cases of sleep apnea even being misdiagnosed as dementia . With the use of treatment through CPAP, there is a reversible risk factor in terms of the amyloid proteins. This usually restores brain structure and diminishes cognitive impairment. There are three types of sleep apnea. OSA accounts for 84%, CSA for 0.9%, and 15% of cases are mixed. In

1120-505: A moderate effect on snoring and mild-to-moderate obstructive sleep apnea" and that more studies with high level of evidence were needed to arrive at a definite conclusion; it also found that the polyester strips work their way out of the soft palate in about 10% of the people in whom they are implanted. Base-of-tongue advancement by means of advancing the genial tubercle of the mandible, tongue suspension, or hyoid suspension (aka hyoid myotomy and suspension or hyoid advancement) may help with

1200-412: A narrow, crowded, or collapsible upper airway, an ineffective pharyngeal dilator muscle function during sleep, airway narrowing during sleep, and unstable control of breathing (high loop gain). In CSA, the basic neurological controls for breathing rate malfunction and fail to give the signal to inhale, causing the individual to miss one or more cycles of breathing. If the pause in breathing is long enough,

1280-632: A non-surgical option for the transverse expansion of the maxilla in adults. This method increases the volume of the nasal cavity and nasopharynx, leading to increased airflow and reduced respiratory arousals during sleep. Changes are permanent with minimal complications. Several surgical procedures ( sleep surgery ) are used to treat sleep apnea, although they are normally a third line of treatment for those who reject or are not helped by CPAP treatment or dental appliances. Surgical treatment for obstructive sleep apnea needs to be individualized to address all anatomical areas of obstruction. Often, correction of

1360-456: A reduction of alveolar ventilation (the clearance of air from the small sacs of the lung where gas exchange takes place) as well as resulting from inhalation of CO 2 . Inability of the lungs to clear carbon dioxide, or inhalation of elevated levels of CO 2 , leads to respiratory acidosis . Eventually the body compensates for the raised acidity by retaining alkali in the kidneys, a process known as "metabolic compensation". Acute hypercapnia

1440-482: A risk factor of COVID-19 . People with OSA have a higher risk of developing severe complications of COVID-19. Alzheimer's disease and severe obstructive sleep apnea are connected because there is an increase in the protein beta-amyloid as well as white-matter damage. These are the main indicators of Alzheimer's, which in this case comes from the lack of proper rest or poorer sleep efficiency resulting in neurodegeneration . Having sleep apnea in mid-life brings

1520-577: A single group in clinical trials. Identifying specific physiological factors underlying sleep apnea makes it possible to test drugs specific to those causal factors: airway narrowing, impaired muscle activity, low arousal threshold for waking, and unstable breathing control. Those who experience low waking thresholds may benefit from eszopiclone , a sedative typically used to treat insomnia. The antidepressant desipramine may stimulate upper airway muscles and lessen pharyngeal collapsibility in people who have limited muscle function in their airways. There

1600-504: A systematic review of published evidence, the United States Preventive Services Task Force in 2017 concluded that there was uncertainty about the accuracy or clinical utility of all potential screening tools for OSA, and recommended that evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. The diagnosis of OSA syndrome is made when

1680-435: A throbbing headache. If associated with a high P a C O 2 {\displaystyle {P_{a_{CO_{2}}}}} the high delivery of oxygen to the brain may increase the risk of CNS oxygen toxicity at partial pressures usually considered acceptable. In many people a high P a C O 2 {\displaystyle {P_{a_{CO_{2}}}}} causes

SECTION 20

#1732779668029

1760-677: A ≥ 4% decrease in pulse oxygenation, or as a ≥ 30% reduction in airflow lasting at least 10 seconds and associated either with a ≥ 3% decrease in pulse oxygenation or with an arousal. To define the severity of the condition, the Apnea-Hypopnea Index (AHI) or the Respiratory Disturbance Index (RDI) are used. While the AHI measures the mean number of apneas and hypopneas per hour of sleep, the RDI adds to this measure

1840-691: Is a hazard of underwater diving associated with breath-hold diving, scuba diving, particularly on rebreathers, and deep diving where it is associated with increased breathing gas density due to the high ambient pressure. Hypercapnia may happen in the context of an underlying health condition, and symptoms may relate to this condition or directly to the hypercapnia. Specific symptoms attributable to early hypercapnia are dyspnea (breathlessness), headache, confusion and lethargy. Clinical signs include flushed skin, full pulse (bounding pulse), rapid breathing , premature heart beats , muscle twitches, and hand flaps ( asterixis ). The risk of dangerous irregularities of

1920-668: Is a normal metabolic product but it accumulates in the body if it is produced faster than it is cleared. During strenuous exercise the production rate of carbon dioxide can increase more than tenfold over the production rate during rest. Carbon dioxide is dissolved in the blood and elimination is by gas exchange in the lungs during breathing. Hypercapnia is generally caused by hypoventilation , lung disease , or diminished consciousness . It may also be caused by exposure to environments containing abnormally high concentrations of carbon dioxide, such as from volcanic or geothermal activity, or by rebreathing exhaled carbon dioxide . In this situation

2000-509: Is a serious medical condition with systemic effects; patients with untreated OSA have a greater mortality risk from cardiovascular disease than those undergoing appropriate treatment. Other complications include hypertension, congestive heart failure, atrial fibrillation, coronary artery disease, stroke, and type 2 diabetes. Daytime fatigue and sleepiness, a common symptom of sleep apnea, is also an important public health concern regarding transportation crashes caused by drowsiness. OSA may also be

2080-488: Is a sleep-related breathing disorder in which repetitive pauses in breathing , periods of shallow breathing, or collapse of the upper airway during sleep results in poor ventilation and sleep disruption. Each pause in breathing can last for a few seconds to a few minutes and occurs many times a night. A choking or snorting sound may occur as breathing resumes. Common symptoms include daytime sleepiness, snoring, and non restorative sleep despite adequate sleep time. Because

2160-632: Is a wide range in presenting symptoms in patients with sleep apnea, from being asymptomatic to falling asleep while driving. Due to this wide range in clinical presentation, some people are not aware that they have sleep apnea and are either misdiagnosed or ignore the symptoms altogether. A current area requiring further study involves identifying different subtypes of sleep apnea based on patients who tend to present with different clusters or groupings of particular symptoms. OSA may increase risk for driving accidents and work-related accidents due to sleep fragmentation from repeated arousals during sleep. If OSA

2240-451: Is available that utilizes the 1997 version of the ESS. It automatically provides the score based on the responses to the ESS questions: ESS interactive calculator . The Epworth Sleepiness Scale has been validated primarily in obstructive sleep apnea , though it has also shown success in detecting narcolepsy and idiopathic hypersomnia . It is used to measure excessive daytime sleepiness and

2320-400: Is being conducted on the potential of using biomarkers to understand which chronic diseases are associated with sleep apnea on an individual basis. Treatment may include lifestyle changes, mouthpieces, breathing devices, and surgery. Effective lifestyle changes may include avoiding alcohol , losing weight, smoking cessation, and sleeping on one's side. Breathing devices include the use of

2400-440: Is called acute hypercapnic respiratory failure ( AHRF ) and is a medical emergency as it generally occurs in the context of acute illness. Chronic hypercapnia, where metabolic compensation is usually present, may cause symptoms but is not generally an emergency. Depending on the scenario both forms of hypercapnia may be treated with medication, with mask-based non-invasive ventilation or with mechanical ventilation . Hypercapnia

2480-578: Is considered the most effective surgery for people with sleep apnea, because it increases the posterior airway space (PAS). However, health professionals are often unsure as to who should be referred for surgery and when to do so: some factors in referral may include failed use of CPAP or device use; anatomy which favors rather than impedes surgery; or significant craniofacial abnormalities which hinder device use. Several inpatient and outpatient procedures use sedation. Many drugs and agents used during surgery to relieve pain and to depress consciousness remain in

Epworth Sleepiness Scale - Misplaced Pages Continue

2560-401: Is first observed by a family member. An in-lab sleep study overnight is the preferred method for diagnosing sleep apnea. In the case of OSA, the outcome that determines disease severity and guides the treatment plan is the apnea-hypopnea index (AHI). This measurement is calculated from totaling all pauses in breathing and periods of shallow breathing lasting greater than 10 seconds and dividing

2640-488: Is limited evidence for medication, but 2012 AASM guidelines suggested that acetazolamide "may be considered" for the treatment of central sleep apnea; zolpidem and triazolam may also be considered for the treatment of central sleep apnea, but "only if the patient does not have underlying risk factors for respiratory depression". Low doses of oxygen are also used as a treatment for hypoxia but are discouraged due to side effects. Hypercapnia Hypercapnia (from

2720-497: Is made when the presence of at least 5 central apnea events occur per hour. There are multiple mechanisms that drive the apnea events. In individuals with heart failure with Cheyne-Stokes respiration, the brain's respiratory control centers are imbalanced during sleep. This results in ventilatory instability, caused by chemoreceptors that are hyperresponsive to CO2 fluctuations in the blood, resulting in high respiratory drive that leads to apnea. Another common mechanism that causes CSA

2800-446: Is not treated it results in excessive daytime sleepiness and oxidative stress from the repeated drops in oxygen saturation, people are at increased risk of other systemic health problems, such as diabetes, hypertension or cardiovascular disease. Subtle manifestations of sleep apnea may include treatment refractory hypertension and cardiac arrhythmias and over time as the disease progresses, more obvious symptoms may become apparent. Due to

2880-443: Is often treated with extracorporeal membrane oxygenation (ECMO), in which oxygen is added to and carbon dioxide removed directly from the blood. A relatively novel modality is extracorporeal carbon dioxide removal (ECCO 2 R). This technique removes CO 2 from the bloodstream and may reduce the time mechanical ventilation is required for those with AHRF; it requires smaller volumes of blood flow compared to ECMO. Hypercapnia

2960-419: Is often used in preference to invasive mechanical ventilation . In the past, the drug doxapram (a respiratory stimulant), was used for hypercapnia in acute exacerbation of chronic obstructive pulmonary disease but there is little evidence to support its use compared to NIV, and it does not feature in recent professional guidelines. Very severe respiratory failure, in which hypercapnia may also be present,

3040-438: Is particularly counterproductive with a rebreather , where the act of breathing pumps the gas around the "loop", pushing carbon dioxide through the scrubber and mixing freshly injected oxygen. In closed-circuit rebreather diving , exhaled carbon dioxide must be removed from the breathing system, usually by a scrubber containing a solid chemical compound with a high affinity for CO 2 , such as soda lime . If not removed from

3120-433: Is post-hyperventilation hypocapnia secondary to heart failure. This occurs because of brief failures of the ventilatory control system but normal alveolar ventilation. In contrast, sleep-related hypoventilation occurs when there is a malfunction of the brain's drive to breathe. The underlying cause of the loss of the wakefulness drive to breathe encompasses a broad set of diseases from strokes to severe kyphoscoliosis. OSA

3200-598: Is repeated after the administration of treatment (e.g., CPAP ) to document improvement of symptoms. In narcolepsy , the Epworth Sleepiness Scale has both a high specificity (100%) and sensitivity (93.5%). The Epworth Sleepiness Scale has been used to compare the sensitivity and specificity of other similar measurements of sleep quality. The Pittsburgh Sleep Quality Index is a related scoring tool of sleep quality. Both scores are internally highly reproducible . The test has limitations that can affect

3280-457: Is the loss of the brain's wakefulness drive to breathe. CSA is organized into 6 individual syndromes: Cheyne-Stokes respiration, Complex sleep apnea, Primary CSA, High altitude periodic breathing, CSA from medication, CSA from comorbidity. Like in OSA, nocturnal polysomnography is the mainstay of diagnosis for CSA. The degree of respiratory effort, measured by esophageal pressure or displacement of

Epworth Sleepiness Scale - Misplaced Pages Continue

3360-570: Is thin, narrow strips of polyester. Three strips are inserted into the roof of the mouth (the soft palate ) using a modified syringe and local anesthetic, in order to stiffen the soft palate. This procedure addresses one of the most common causes of snoring and sleep apnea — vibration or collapse of the soft palate. It was approved by the FDA for snoring in 2002 and for obstructive sleep apnea in 2004. A 2013 meta-analysis found that "the Pillar implant has

3440-527: Is unknown but is most likely related to incorrect settings of the CPAP treatment and other medical conditions the person has. The treatment of obstructive sleep apnea is different than that of central sleep apnea. Treatment often starts with behavioral therapy and some people may be suggested to try a continuous positive airway pressure device. Many people are told to avoid alcohol, sleeping pills, and other sedatives, which can relax throat muscles, contributing to

3520-451: The Greek hyper = "above" or "too much" and kapnos = " smoke "), also known as hypercarbia and CO 2 retention , is a condition of abnormally elevated carbon dioxide (CO 2 ) levels in the blood. Carbon dioxide is a gaseous product of the body's metabolism and is normally expelled through the lungs . Carbon dioxide may accumulate in any condition that causes hypoventilation ,

3600-454: The 10–24 range indicates that expert medical advice should be sought. For instance, scores of 11–15 are shown to indicate the possibility of mild to moderate sleep apnea , where a score of 16 and above indicates the possibility of severe sleep apnea or narcolepsy . Certain questions in the scale were shown to be better predictors of specific sleep disorders, though further tests may be required to provide an accurate diagnosis. The questionnaire

3680-1171: The Epworth Sleepiness Scale (ESS), a self-reported questionnaire on the propensity to fall asleep or doze off during daytime. Screening tools for OSA itself comprise the STOP questionnaire, the Berlin questionnaire and the STOP-BANG questionnaire which has been reported as being a very powerful tool to detect OSA. According to the International Classification of Sleep Disorders , there are 4 types of criteria. The first one concerns sleep – excessive sleepiness, nonrestorative sleep, fatigue or insomnia symptoms. The second and third criteria are about respiration – waking with breath holding, gasping, or choking; snoring, breathing interruptions or both during sleep. The last criterion revolved around medical issues as hypertension, coronary artery disease, stroke, heart failure, atrial fibrillation, type 2 diabetes mellitus, mood disorder or cognitive impairment. Two levels of severity are distinguished,

3760-496: The back of their throat which can restrict the airway, especially when sleeping. In weight loss studies of overweight individuals, those who lose weight show reduced apnea frequencies and improved apnoea–hypopnoea index (AHI). Weight loss effective enough to relieve obesity hypoventilation syndrome (OHS) must be 25–30% of body weight. For some obese people, it can be difficult to achieve and maintain this result without bariatric surgery . In children, orthodontic treatment to expand

3840-478: The body at low amounts for hours or even days afterwards. In an individual with either central, obstructive or mixed sleep apnea, these low doses may be enough to cause life-threatening irregularities in breathing or collapses in a patient's airways. Use of analgesics and sedatives in these patients postoperatively should therefore be minimized or avoided. Surgery on the mouth and throat, as well as dental surgery and procedures, can result in postoperative swelling of

3920-565: The chest and abdomen to detect motion, an ECG lead, and EMG sensors to detect muscle contraction in the chin, chest, and legs. A hypopnea can be based on one of two criteria. It can either be a reduction in airflow of at least 30% for more than 10 seconds associated with at least 4% oxygen desaturation or a reduction in airflow of at least 30% for more than 10 seconds associated with at least 3% oxygen desaturation or an arousal from sleep on EEG. An "event" can be either an apnea, characterized by complete cessation of airflow for at least 10 seconds, or

4000-462: The collapse of the airway at night. The evidence supporting one treatment option compared to another for a particular person is not clear. More than half of people with obstructive sleep apnea have some degree of positional obstructive sleep apnea, meaning that it gets worse when they sleep on their backs. Sleeping on their sides is an effective and cost-effective treatment for positional obstructive sleep apnea. For moderate to severe sleep apnea,

4080-703: The concentration of bicarbonate ion, P a C O 2 / H C O 3 − {\displaystyle {P_{a_{CO_{2}/HCO_{3}^{-}}}}} . Tests performed on mongrel dogs showed the physiological effect of carbon dioxide on the body of the animal: after inhalation of a 50% CO 2 and 50% air mixture, respiratory movement increased for about 2 minutes, and then, it decreased for 30 to 90 minutes. Hill and Flack showed that CO 2 concentrations up to 35% have an exciting effect upon both circulation and respiration, but those beyond 35% are depressant upon them. The blood pressure (BP) decreased transiently during

SECTION 50

#1732779668029

4160-407: The control of the subject, sometimes with little or no warning. Vasodilation is another effect, notably in the skin, where feelings of unpleasant heat are reported, and in the brain, where blood flow can increase by 50% at a P E T C O 2 {\displaystyle {P_{ET_{CO_{2}}}}} of 50 torrs (0.066 atm), Intracranial pressure may rise, with

4240-471: The decrease of output of the brainstem regulating the chest wall or pharyngeal muscles, which causes the pharynx to collapse. People with sleep apnea experience reduced or no slow-wave sleep and spend less time in REM sleep . Central sleep apnea There are two main mechanism that drive the disease process of CSA, sleep-related hypoventilation and post-hyperventilation hypocapnia. The most common cause of CSA

4320-455: The disorder disrupts normal sleep, those affected may experience sleepiness or feel tired during the day. It is often a chronic condition. Sleep apnea may be categorized as obstructive sleep apnea (OSA), in which breathing is interrupted by a blockage of air flow, central sleep apnea (CSA), in which regular unconscious breath simply stops, or a combination of the two. OSA is the most common form. OSA has four key contributors; these include

4400-403: The disruption in daytime cognitive state, behavioral effects may be present. These can include moodiness, belligerence, as well as a decrease in attentiveness and energy. These effects may become intractable, leading to depression. Obstructive sleep apnea can affect people regardless of sex, race, or age. However, risk factors include: Central sleep apnea is more often associated with any of

4480-407: The diver exhales: Skip breathing is a controversial technique to conserve breathing gas when using open-circuit scuba , which consists of briefly holding one's breath between inhalation and exhalation (i.e., "skipping" a breath). It can lead to CO 2 not being exhaled efficiently. The risk of burst lung ( pulmonary barotrauma of ascent) is increased if the breath is held while ascending. It

4560-575: The first one is determined by a polysomnography or home sleep apnea test demonstrating 5 or more predominantly obstructive respiratory events per hour of sleep and the higher levels are determined by 15 or more events. If the events are present less than 5 times per hour, no obstructive sleep apnea is diagnosed. A considerable night-to-night variability further complicates diagnosis of OSA. In unclear cases, multiple nights of testing might be required to achieve an accurate diagnosis. Since sequential nights of testing would be impractical and cost prohibitive in

4640-461: The following risk factors: Obstructive sleep apnea The causes of obstructive sleep apnea are complex and individualized, but typical risk factors include narrow pharyngeal anatomy and craniofacial structure. When anatomical risk factors are combined with non-anatomical contributors such as an ineffective pharyngeal dilator muscle function during sleep, unstable control of breathing (high loop gain), and premature awakening to mild airway narrowing,

4720-619: The heart beat is increased. Hypercapnia also occurs when the breathing gas is contaminated with carbon dioxide, or respiratory gas exchange cannot keep up with the metabolic production of carbon dioxide, which can occur when gas density limits ventilation at high ambient pressures. In severe hypercapnia (generally P a C O 2 {\displaystyle {P_{a_{CO_{2}}}}} greater than 10 kPa or 75 mmHg ), symptomatology progresses to disorientation, panic , hyperventilation , convulsions , unconsciousness , and eventually death . Carbon dioxide

4800-496: The hypercapnia can also be accompanied by respiratory acidosis . Acute hypercapnic respiratory failure may occur in acute illness caused by chronic obstructive pulmonary disease (COPD), chest wall deformity, some forms of neuromuscular disease (such as myasthenia gravis ), and obesity hypoventilation syndrome . AHRF may also develop in any form of respiratory failure where the breathing muscles become exhausted, such as severe pneumonia and acute severe asthma . It can also be

4880-418: The increased respiratory movement and then rose again and maintained the original level for a while. The heart rate slowed slightly just after the gas mixture inhalation. It is believed that the initial BP depression with the decreased heart rate is due to the direct depressant effect of CO 2 upon the heart and that the return of blood pressure to its original level was due to the rapid rise of P

SECTION 60

#1732779668029

4960-542: The lining of the mouth and other areas that affect the airway. Even when the surgical procedure is designed to improve the airway, such as tonsillectomy and adenoidectomy or tongue reduction, swelling may negate some of the effects in the immediate postoperative period. Once the swelling resolves and the palate becomes tightened by postoperative scarring, however, the full benefit of the surgery may be noticed. A person with sleep apnea undergoing any medical treatment must make sure their doctor and anesthetist are informed about

5040-413: The lower pharynx. Other surgery options may attempt to shrink or stiffen excess tissue in the mouth or throat, procedures done at either a doctor's office or a hospital. Small shots or other treatments, sometimes in a series, are used for shrinkage, while the insertion of a small piece of stiff plastic is used in the case of surgery whose goal is to stiffen tissues. Maxillomandibular advancement (MMA)

5120-679: The most common treatment is the use of a continuous positive airway pressure (CPAP) or automatic positive airway pressure (APAP) device. These splint the person's airway open during sleep by means of pressurized air. The person typically wears a plastic facial mask, which is connected by a flexible tube to a small bedside CPAP machine. Although CPAP therapy is effective in reducing apneas and less expensive than other treatments, some people find it uncomfortable. Some complain of feeling trapped, having chest discomfort, and skin or nose irritation. Other side effects may include dry mouth, dry nose, nosebleeds, sore lips and gums. Whether or not it decreases

5200-442: The nasal passages needs to be performed in addition to correction of the oropharynx passage. Septoplasty and turbinate surgery may improve the nasal airway, but has been found to be ineffective at reducing respiratory arousals during sleep. Tonsillectomy and uvulopalatopharyngoplasty (UPPP or UP3) are available to address pharyngeal obstruction. The "Pillar" device is a treatment for snoring and obstructive sleep apnea; it

5280-431: The patient shows recurrent episodes of partial or complete collapse of the upper airway during sleep resulting in apneas or hypopneas, respectively. Criteria defining an apnea or a hypopnea vary. The American Academy of Sleep Medicine (AASM) defines an apnea as a reduction in airflow of ≥ 90% lasting at least 10 seconds. A hypopnea is defined as a reduction in airflow of ≥ 30% lasting at least 10 seconds and associated with

5360-421: The percentage of oxygen in the circulation can drop to a lower than normal level ( hypoxaemia ) and the concentration of carbon dioxide can build to a higher than normal level ( hypercapnia ). In turn, these conditions of hypoxia and hypercapnia will trigger additional effects on the body such as Cheyne-Stokes Respiration . Some people with sleep apnea are unaware they have the condition. In many cases it

5440-496: The respiratory effort-related arousals (RERAs). The OSA syndrome is thus diagnosed if the AHI is > 5 episodes per hour and results in daytime sleepiness and fatigue or when the RDI is ≥ 15 independently of the symptoms. According to the American Association of Sleep Medicine, daytime sleepiness is determined as mild, moderate and severe depending on its impact on social life. Daytime sleepiness can be assessed with

5520-442: The risk of heart attack , stroke , diabetes , heart failure , irregular heartbeat , obesity , and motor vehicle collisions . OSA is a common sleep disorder. A large analysis in 2019 of the estimated prevalence of OSA found that OSA affects 936 million—1 billion people between the ages of 30–69 globally, or roughly every 1 in 10 people, and up to 30% of the elderly. Sleep apnea is somewhat more common in men than women, roughly

5600-408: The risk of death or heart disease is controversial with some reviews finding benefit and others not. This variation across studies might be driven by low rates of compliance—analyses of those who use CPAP for at least four hours a night suggests a decrease in cardiovascular events. Excess body weight is thought to be an important cause of sleep apnea. People who are overweight have more tissues in

5680-430: The setting of acute breathing problems or other acute medical illness. Hypercapnia is generally defined as an arterial blood carbon dioxide level over 45 mmHg (6 kPa). Since carbon dioxide is in equilibrium with carbonic acid in the blood, hypercapnia drives serum pH down, resulting in respiratory acidosis. Clinically, the effect of hypercapnia on pH is estimated using the ratio of the arterial pressure of carbon dioxide to

5760-476: The severity of the OSA rapidly increases as more factors are present. When breathing is paused due to upper airway obstruction, carbon dioxide builds up in the bloodstream. Chemoreceptors in the bloodstream note the high carbon dioxide levels. The brain is signaled to awaken the person, which clears the airway and allows breathing to resume. Breathing normally will restore oxygen levels and the person will fall asleep again. This carbon dioxide build-up may be due to

5840-422: The sleep apnea. Alternative and emergency procedures may be necessary to maintain the airway of sleep apnea patients. Diaphragm pacing , which involves the rhythmic application of electrical impulses to the diaphragm, has been used to treat central sleep apnea. In April 2014, the U.S. Food and Drug Administration granted pre-market approval for use of an upper airway stimulation system in people who cannot use

5920-440: The sleep lab, home sleep testing for multiple nights can not only be more useful, but more reflective of what is typically happening each night. Nighttime in-laboratory Level 1 polysomnography (PSG) is the gold standard test for diagnosis. Patients are monitored with EEG leads, pulse oximetry , temperature and pressure sensors to detect nasal and oral airflow, respiratory impedance plethysmography or similar resistance belts around

6000-562: The sum by total hours of recorded sleep. In contrast, for CSA the degree of respiratory effort, measured by esophageal pressure or displacement of the thoracic or abdominal cavity, is an important distinguishing factor between OSA and CSA. A systemic disorder, sleep apnea is associated with a wide array of effects, including increased risk of car accidents , hypertension , cardiovascular disease , myocardial infarction , stroke , atrial fibrillation , insulin resistance , higher incidence of cancer , and neurodegeneration . Further research

6080-473: The system, it may be reinhaled, causing an increase in the inhaled concentration. Under hyperbaric conditions, hypercapnia contributes to nitrogen narcosis and oxygen toxicity by causing cerebral vasodilation which increases the dosage of oxygen to the brain. Hypercapnia normally triggers a reflex which increases breathing and access to oxygen (O 2 ), such as arousal and turning the head during sleep. A failure of this reflex can be fatal, for example as

6160-515: The test's accuracy. The test is based on subjectivity and therefore may not be accurate when factors such as: the test takers opinions on their sleep, how others view their sleepiness, education level, and others are considered. The test can be biased as pre-emptive discussion of results can have an effect on the responses while the test is being taken. Sleep apnea Sleep apnea ( sleep apnoea or sleep apnœa in British English)

6240-447: The thoracic or abdominal cavity, is an important distinguishing factor between OSA and CSA. Some people with sleep apnea have a combination of both types; its prevalence ranges from 0.56% to 18%. The condition, also called treatment-emergent central apnea, is generally detected when obstructive sleep apnea is treated with CPAP and central sleep apnea emerges. The exact mechanism of the loss of central respiratory drive during sleep in OSA

6320-401: The volume of the nasal airway, such as nonsurgical rapid palatal expansion is common. The procedure has been found to significantly decrease the AHI and lead to long-term resolution of clinical symptoms. Since the palatal suture is fused in adults, regular RPE using tooth-borne expanders cannot be performed. Mini-implant assisted rapid palatal expansion (MARPE) has been recently developed as

6400-408: Was originally created with the intent to preserve the exact wording of the questionnaire to provide a standardized test and preserve its validity . Johns, the author of the ESS, recommends that the administrator of the questionnaire does not discuss the results of the test with the subject until it is completed, as it could affect the subject's responses on the questionnaire. An interactive calculator

#28971